JP2019055932A - Composition for dj-1 protein production promotion - Google Patents
Composition for dj-1 protein production promotion Download PDFInfo
- Publication number
- JP2019055932A JP2019055932A JP2017217996A JP2017217996A JP2019055932A JP 2019055932 A JP2019055932 A JP 2019055932A JP 2017217996 A JP2017217996 A JP 2017217996A JP 2017217996 A JP2017217996 A JP 2017217996A JP 2019055932 A JP2019055932 A JP 2019055932A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- protein
- skin
- curcumin
- resveratrol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 34
- 230000014616 translation Effects 0.000 title claims abstract description 13
- 102000007659 Protein Deglycase DJ-1 Human genes 0.000 claims abstract description 44
- 108010032428 Protein Deglycase DJ-1 Proteins 0.000 claims abstract description 44
- 235000021283 resveratrol Nutrition 0.000 claims abstract description 30
- 235000012754 curcumin Nutrition 0.000 claims abstract description 29
- 210000003491 skin Anatomy 0.000 claims abstract description 18
- 210000004927 skin cell Anatomy 0.000 claims abstract description 12
- 238000002360 preparation method Methods 0.000 claims abstract description 11
- 239000004480 active ingredient Substances 0.000 claims abstract description 7
- 230000002708 enhancing effect Effects 0.000 claims abstract description 3
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 55
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 29
- 229940109262 curcumin Drugs 0.000 claims description 28
- 239000004148 curcumin Substances 0.000 claims description 28
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims description 27
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 26
- 229940016667 resveratrol Drugs 0.000 claims description 26
- 230000001737 promoting effect Effects 0.000 claims description 12
- 230000000638 stimulation Effects 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 13
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 16
- -1 polyphenol compounds Chemical class 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 238000000034 method Methods 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 230000003833 cell viability Effects 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 244000163122 Curcuma domestica Species 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 235000003373 curcuma longa Nutrition 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 235000003392 Curcuma domestica Nutrition 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 210000001339 epidermal cell Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000016273 neuron death Effects 0.000 description 3
- 230000036542 oxidative stress Effects 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 235000013976 turmeric Nutrition 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- FQWLMRXWKZGLFI-YVYUXZJTSA-N (-)-trans-epsilon-viniferin Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC2=C1[C@@H](C=1C=C(O)C=C(O)C=1)[C@H](C=1C=CC(O)=CC=1)O2 FQWLMRXWKZGLFI-YVYUXZJTSA-N 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 208000018737 Parkinson disease Diseases 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 230000006750 UV protection Effects 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- DIVDFFZHCJEHGG-UHFFFAOYSA-N oxidopamine Chemical compound NCCC1=CC(O)=C(O)C=C1O DIVDFFZHCJEHGG-UHFFFAOYSA-N 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 229940052016 turmeric extract Drugs 0.000 description 2
- 235000020240 turmeric extract Nutrition 0.000 description 2
- 239000008513 turmeric extract Substances 0.000 description 2
- 238000003026 viability measurement method Methods 0.000 description 2
- UEPVWRDHSPMIAZ-IZTHOABVSA-N (1e,4z,6e)-5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)hepta-1,4,6-trien-3-one Chemical compound C1=C(O)C(OC)=CC(\C=C\C(\O)=C\C(=O)\C=C\C=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-IZTHOABVSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- GECRRQVLQHRVNH-MRCUWXFGSA-N 2-octyldodecyl (z)-octadec-9-enoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC GECRRQVLQHRVNH-MRCUWXFGSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- PYIXHKGTJKCVBJ-UHFFFAOYSA-N Astraciceran Natural products C1OC2=CC(O)=CC=C2CC1C1=CC(OCO2)=C2C=C1OC PYIXHKGTJKCVBJ-UHFFFAOYSA-N 0.000 description 1
- NDVRQFZUJRMKKP-UHFFFAOYSA-N Betavulgarin Natural products O=C1C=2C(OC)=C3OCOC3=CC=2OC=C1C1=CC=CC=C1O NDVRQFZUJRMKKP-UHFFFAOYSA-N 0.000 description 1
- HJTVQHVGMGKONQ-LUZURFALSA-N Curcumin II Natural products C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=CC(O)=CC=2)=C1 HJTVQHVGMGKONQ-LUZURFALSA-N 0.000 description 1
- IZLBLUIBVMGMIY-ZZXKWVIFSA-N Cyclocurcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C=2OC(CC(=O)C=2)C=2C=C(OC)C(O)=CC=2)=C1 IZLBLUIBVMGMIY-ZZXKWVIFSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000601727 Homo sapiens Parkinson disease protein 7 Proteins 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- IHPVFYLOGNNZLA-UHFFFAOYSA-N Phytoalexin Natural products COC1=CC=CC=C1C1OC(C=C2C(OCO2)=C2OC)=C2C(=O)C1 IHPVFYLOGNNZLA-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 238000003349 alamar blue assay Methods 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 229940024546 aluminum hydroxide gel Drugs 0.000 description 1
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- JYTVKRNTTALBBZ-UHFFFAOYSA-N bis demethoxycurcumin Natural products C1=CC(O)=CC=C1C=CC(=O)CC(=O)C=CC1=CC=CC(O)=C1 JYTVKRNTTALBBZ-UHFFFAOYSA-N 0.000 description 1
- PREBVFJICNPEKM-YDWXAUTNSA-N bisdemethoxycurcumin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)CC(=O)\C=C\C1=CC=C(O)C=C1 PREBVFJICNPEKM-YDWXAUTNSA-N 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- FQWLMRXWKZGLFI-UHFFFAOYSA-N cis epsilon-viniferine Natural products C1=CC(O)=CC=C1C=CC1=CC(O)=CC2=C1C(C=1C=C(O)C=C(O)C=1)C(C=1C=CC(O)=CC=1)O2 FQWLMRXWKZGLFI-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- IZLBLUIBVMGMIY-UHFFFAOYSA-N cyclocurcumin Natural products C1=C(O)C(OC)=CC(C=CC=2OC(CC(=O)C=2)C=2C=C(OC)C(O)=CC=2)=C1 IZLBLUIBVMGMIY-UHFFFAOYSA-N 0.000 description 1
- NMRUIRRIQNAQEB-UHFFFAOYSA-N demethoxycurcumin Natural products OC(=CC(C=CC1=CC(=C(C=C1)O)OC)=O)C=CC1=CC=C(C=C1)O NMRUIRRIQNAQEB-UHFFFAOYSA-N 0.000 description 1
- YXAKCQIIROBKOP-UHFFFAOYSA-N di-p-hydroxycinnamoylmethane Natural products C=1C=C(O)C=CC=1C=CC(=O)C=C(O)C=CC1=CC=C(O)C=C1 YXAKCQIIROBKOP-UHFFFAOYSA-N 0.000 description 1
- 125000005131 dialkylammonium group Chemical group 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- SXRAUGAFMDOHKN-UHFFFAOYSA-N epsilon-viniferin Natural products CC1(Oc2cc(O)cc(C=Cc3ccc(O)cc3)c2C1(C)c4cc(O)cc(O)c4)c5ccc(O)cc5 SXRAUGAFMDOHKN-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 102000054831 human PARK7 Human genes 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- UEPVWRDHSPMIAZ-UHFFFAOYSA-N p-hydroxycinnamoyl feruloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(O)=CC(=O)C=CC=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-UHFFFAOYSA-N 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000280 phytoalexin Substances 0.000 description 1
- 150000001857 phytoalexin derivatives Chemical class 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical class C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 150000003436 stilbenoids Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical class CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Abstract
Description
本発明は、ＤＪ−１タンパク質の産生を促進する組成物、及び皮膚細胞に対する外部刺激抵抗性を増強する組成物に関する。 The present invention relates to a composition that promotes the production of DJ-1 protein and a composition that enhances resistance to external stimuli against skin cells.
ＤＪ−１タンパク質は、公知の生理活性タンパク質で、神経細胞や皮膚細胞を含む広範なヒト細胞に存在しており、１８９のアミノ酸からなる。ＤＪ−１タンパク質はガン遺伝子産物であり、家族性パーキンソン病と関連があることが知られている（非特許文献１）。
さらに、ＤＪ−１タンパク質は酸化ストレスによる神経細胞死を抑制する効果を有することが知られている。すなわち、酸化ストレスを与える６−ヒドロキシドーパミンを注入されたパーキンソン病モデルラットに、６−ヒドロキシドーパミンの注入と同時又は注入後にＤＪ−１タンパク質を注入すると、ドーパミン神経細胞死が抑制され、行動異常が改善されることが知られている（特許文献１）。
特許文献１には、酸化ストレスによる神経細胞死を抑制する効果をＤＪ−１が有することが記載されている。そしてＤＪ−１に結合し、活性化する化合物を提案している。
The DJ-1 protein is a known physiologically active protein and is present in a wide range of human cells including nerve cells and skin cells, and consists of 189 amino acids. DJ-1 protein is an oncogene product and is known to be associated with familial Parkinson's disease (Non-patent Document 1).
Furthermore, it is known that DJ-1 protein has an effect of suppressing neuronal cell death due to oxidative stress. That is, when DJ-1 protein is injected into Parkinson's disease model rats injected with 6-hydroxydopamine giving oxidative stress at the same time as or after 6-hydroxydopamine injection, dopamine neuronal cell death is suppressed and behavioral abnormalities are observed. It is known to be improved (Patent Document 1).
Patent Document 1 describes that DJ-1 has an effect of suppressing neuronal cell death caused by oxidative stress. And the compound which couple | bonds with DJ-1 and activates is proposed.
またＤＪ−１タンパク質は、皮膚の抵抗性に関与していることが知られている。本発明者らは、皮膚角層中のＤＪ−１タンパク質量を測定することによって紫外線に曝露したときの発赤の発生に対する抵抗性の指標とすることができること（特許文献２）、紫外線曝露歴の評価指標とすることができること（特許文献３）、あるいは発毛状態の評価指標とできること（特許文献４）などを明らかにしている。 DJ-1 protein is known to be involved in skin resistance. The present inventors can measure the amount of DJ-1 protein in the stratum corneum as an index of resistance to the occurrence of redness when exposed to ultraviolet rays (Patent Document 2). It is clarified that it can be used as an evaluation index (Patent Document 3), or an evaluation index of a hair growth state (Patent Document 4).
本発明は、皮膚の外部刺激に対する抵抗性に関与するＤＪ−１タンパク質の産生を促進する物質を探索する過程で見出されたものである。また、本発明者らは紫外線が皮膚細胞に及ぼす影響を検討する過程でＤＪ−１タンパク質が増加した細胞は紫外線抵抗性が増強していることを見いだした。
すなわち本発明は、皮膚細胞のＤＪ−１タンパク質産生を促進する新たな組成物を提供すること、及び紫外線抵抗性を皮膚細胞に付与するための組成物を提供することを課題とする。
The present invention was discovered in the process of searching for a substance that promotes the production of DJ-1 protein involved in resistance to external stimulation of the skin. In addition, the present inventors have found that cells with increased DJ-1 protein have enhanced UV resistance in the process of examining the effect of UV rays on skin cells.
That is, an object of the present invention is to provide a new composition for promoting the production of DJ-1 protein in skin cells and to provide a composition for imparting ultraviolet resistance to skin cells.
本発明は以下の構成である。
（１）クルクミン類及び／又はレスベラトロール類を有効成分として含有するＤＪ−１タンパク質産生促進用組成物。
（２）（１）に記載の組成物を含むＤＪ−１タンパク質産生促進のための皮膚外用剤。
（３）（１）に記載の組成物を含む皮膚細胞の外部刺激抵抗性を増強するための組成物。
（４）外部刺激が紫外線によるものである（３）に記載の組成物。
（５）紫外線曝露によって誘発される赤み（発赤）発生に対する抵抗性向上剤。
The present invention has the following configuration.
(1) A composition for promoting DJ-1 protein production comprising curcumin and / or resveratrol as an active ingredient.
(2) A skin external preparation for promoting DJ-1 protein production, comprising the composition according to (1).
(3) A composition for enhancing resistance to external stimulation of skin cells, comprising the composition according to (1).
(4) The composition according to (3), wherein the external stimulus is an ultraviolet ray.
(5) A resistance improver against redness (redness) generation induced by ultraviolet exposure.
本発明により、ＤＪ−１タンパク質の産生を促進する組成物が提供される。本発明の組成物は皮膚外用剤として有用である。またあらかじめ、皮膚細胞、特に角層細胞におけるＤＪ−１タンパク質を増加させておくことで、外部刺激に対する細胞の抵抗性が増強され、紫外線によって誘発される炎症反応などを抑制することができる。このため紫外線曝露によって誘発される炎症や発赤に対する抵抗性を向上させることができる。 The present invention provides a composition that promotes the production of DJ-1 protein. The composition of the present invention is useful as a skin external preparation. Further, by increasing the DJ-1 protein in skin cells, particularly stratum corneum cells, the resistance of the cells to external stimuli is enhanced, and the inflammatory reaction induced by ultraviolet rays can be suppressed. For this reason, resistance to inflammation and redness induced by exposure to ultraviolet rays can be improved.
以下、本発明について詳細に説明する。
本願はクルクミン類及び／又はレスベラトロール類を有効成分として含有するＤＪ−１タンパク質産生促進用組成物に係る発明である。
Hereinafter, the present invention will be described in detail.
The present application is an invention relating to a composition for promoting production of DJ-1 protein containing curcumin and / or resveratrol as an active ingredient.
ヒトＤＪ−１タンパク質は、前記したとおり、ヒト皮膚細胞や神経細胞において多く発現されるタンパク質である。
皮膚のＤＪ−１タンパク質産生を促進することにより、皮膚内のＤＪ−１タンパク質量を増加させ、皮膚の外部刺激に対する抵抗性を増加させることが期待できる。
As described above, human DJ-1 protein is a protein that is highly expressed in human skin cells and nerve cells.
By promoting the production of DJ-1 protein in the skin, it can be expected that the amount of DJ-1 protein in the skin is increased and the resistance to external stimulation of the skin is increased.
本発明のＤＪ−１タンパク質産生促進用組成物は、クルクミン類及び／又はレスベラトロール類をＤＪ−１タンパク質産生促進の有効成分として含有している。 The composition for promoting production of DJ-1 protein of the present invention contains curcumin and / or resveratrol as an active ingredient for promoting production of DJ-1 protein.
本発明の組成物の有効成分であるクルクミン (ｃｕｒｃｕｍｉｎ) 類は、ウコン（ターメリック、学名Ｃｕｒｃｕｍａ ｌｏｎｇａ）などに含まれる黄色の、公知のポリフェノール化合物の総称である。スパイスや食品領域の着色剤として利用され、安全性も熟知されている。
本発明に用いるクルクミン類は、クルクミンまたはクルクミン誘導体として分類される化合物をいい、クルクミン、デメトキシクルクミン、ビスデメトキシクルクミン、シス−トランス−クルクミン、およびシクロクルクミンを含むが、これに限定されない。なかでもクルクミンが特に好ましい。また、植物ウコンの根茎から抽出されたウコン抽出物であってもよい。ウコン抽出物は健康食品やサプリメントの原料として市販されており、このような市販品を用いることもできる。
Curcumin, which is an active ingredient of the composition of the present invention, is a generic name for yellow known polyphenol compounds contained in turmeric (turmeric, scientific name Curcuma longa) and the like. It is used as a colorant for spices and foods and is well known for its safety.
Curcumins used in the present invention refer to compounds classified as curcumin or curcumin derivatives, including but not limited to curcumin, demethoxycurcumin, bisdemethoxycurcumin, cis-trans-curcumin, and cyclocurcumin. Of these, curcumin is particularly preferable. Moreover, the turmeric extract extracted from the rhizome of the plant turmeric may be sufficient. Turmeric extract is commercially available as a raw material for health foods and supplements, and such commercially available products can also be used.
レスベラトロール（ｒｅｓｖｅｒａｔｒｏｌ）はスチルベノイド（スチルベン誘導体）ポリフェノールの一種であって、系統名は３，５，４’−トリヒドロキシ−ｔｒａｎｓ−スチルベンとも呼ばれる。レスベラトロールは、いくつかの植物でファイトアレキシンとして機能しており、またブドウの果皮などにも含まれる抗酸化物質として知られている。レスベラトロールは二量体を形成し、ε−ビニフェリンとも呼ばれる。また配糖体も存在しており、本発明においては、これらを総称してレスベラトロール類と呼ぶ。レスベラトロール類の中でも、単量体のレスベラトロールが好ましい。レスベラトロール類は、ブドウの果皮や赤ワイン、ピーナッツの赤皮、メリンジョ（グネツム）、イタドリの根から得ることができる。健康食品の原料として販売されており、これを使用することもできる。 Resveratrol is a kind of stilbenoid (stilbene derivative) polyphenol, and the systematic name is also called 3,5,4'-trihydroxy-trans-stilbene. Resveratrol functions as a phytoalexin in some plants and is also known as an antioxidant contained in grape skins. Resveratrol forms a dimer and is also called ε-viniferin. Glycosides also exist, and in the present invention, these are collectively referred to as resveratrols. Among the resveratrols, monomeric resveratrol is preferable. Resveratrols can be obtained from grape skins, red wine, peanut red skin, merinjo (Gnetsum) and itadori roots. It is sold as a raw material for health foods and can be used.
本発明のＤＪ−１タンパク質産生促進用組成物として医薬品、医薬部外品、化粧品、食品、飲料などを例示できる。その投与経路は、経口投与、経皮投与のいずれも可能である。なかでも経皮投与が特に好ましく、化粧品や皮膚外用医薬などの経皮組成物の形態を採用することが好ましい。経口投与などにより、有効成分を皮膚に到達させることもできる。
ＤＪ−１タンパク質産生促進用組成物とするためには、例えば外用剤とする場合、クルクミン類及び／又はレスベラトロール類を、クルクミン換算で、外用剤質量当たり０．００１〜０．１質量％、あるいはレスベラトロール換算で外用剤質量当たり０．０１〜１質量％含有させることで、皮膚に塗布等の方法で外用すると皮膚細胞のＤＪ−１タンパク質を産生促進できる。なおＤＪ−１タンパク質の産生促進効果を確認するためには、テープストリッピング法などによって皮膚角層試料を採取して、これを特許文献２に記載された操作方法に従って抽出し、ＥＬＩＳＡ法などで測定する。
Examples of the composition for promoting production of DJ-1 protein of the present invention include pharmaceuticals, quasi drugs, cosmetics, foods, and beverages. The administration route can be either oral administration or transdermal administration. Of these, transdermal administration is particularly preferable, and it is preferable to adopt the form of a transdermal composition such as cosmetics and external medicine for skin. The active ingredient can also reach the skin by oral administration or the like.
In order to obtain a composition for promoting the production of DJ-1 protein, for example, when it is used as an external preparation, curcumin and / or resveratrol is converted into curcumin in an amount of 0.001 to 0.1% by mass per external preparation mass. Alternatively, by containing 0.01 to 1% by mass of the external preparation mass in terms of resveratrol, the production of the skin cell DJ-1 protein can be promoted by external application by a method such as application to the skin. In order to confirm the production promotion effect of DJ-1 protein, a skin stratum corneum sample is collected by a tape stripping method or the like, extracted according to the operation method described in Patent Document 2, and measured by an ELISA method or the like. To do.
本発明のクルクミン類及び／又はレスベラトロール類を含むＤＪ−１タンパク質産生促進用組成物を人に投与する製剤とするために、通常の食品、医薬品、化粧料などの製剤化で使用される任意成分を含有することができる。このような任意成分としては、経口投与組成物であれば、例えば、乳糖や白糖などの賦形剤、デンプン、セルロース、アラビアガム、ヒドロキシプロピルセルロースなどの結合剤、カルボキシメチルセルロースナトリウム、カルボキシメチルセルロースカルシウムなどの崩壊剤、大豆レシチン、ショ糖脂肪酸エステルなどの界面活性剤、マルチトールやソルビトールなどの甘味剤、クエン酸などの酸味剤、リン酸塩などの緩衝剤、シェラックやツェインなどの皮膜形成剤、タルク、ロウ類などの滑沢剤、軽質無水ケイ酸、乾燥水酸化アルミニウムゲルなどの流動促進剤、生理食塩水、ブドウ糖水溶液などの希釈剤、矯味矯臭剤、着色剤、殺菌剤、防腐剤、香料などが好適に例示できる。経皮投与組成物であれば、スクワラン、ワセリン、マイクロクリスタリンワックスなどの炭化水素類、ホホバ油、カルナウバワックス、オレイン酸オクチルドデシルなどのエステル類、オリーブ油、牛脂、椰子油などのトリグリセライド類、ステアリン酸、オレイン酸、レチノイン酸などの脂肪酸、エタノール、イソプロパノール等の低級アルコール、オレイルアルコール、ステアリルアルコール、オクチルドデカノール等の高級アルコール、スルホコハク酸エステルやポリオキシエチレンアルキル硫酸ナトリウム等のアニオン界面活性剤類、アルキルベタイン塩等の両性界面活性剤類、ジアルキルアンモニウム塩等のカチオン界面活性剤類、ソルビタン脂肪酸エステル、脂肪酸モノグリセライド、これらのポリオキシエチレン付加物、ポリオキシエチレンアルキルエーテル、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンヒマシ油、ポリオキシエチレン硬化ヒマシ油等の非イオン界面活性剤類、ジプロピレングリコール、ポリエチレングリコール、グリセリン、１，３−ブタンジオール、１，２−ペンタンジオール等の多価アルコール類、増粘・ゲル化剤、酸化防止剤、紫外線吸収剤、色剤、防腐剤、粉体等を含有することができる。投与製剤としては、化粧料や塗布剤、貼付剤などの外用剤の形態が好ましい。 In order to obtain a preparation for administering a composition for promoting the production of DJ-1 protein containing curcumin and / or resveratrol of the present invention to humans, it is used in the preparation of ordinary foods, pharmaceuticals, cosmetics and the like. Optional ingredients can be included. As such an optional component, if it is a composition for oral administration, for example, excipients such as lactose and sucrose, binders such as starch, cellulose, gum arabic and hydroxypropyl cellulose, sodium carboxymethylcellulose, carboxymethylcellulose calcium and the like Disintegrants, soy lecithin, surfactants such as sucrose fatty acid esters, sweeteners such as maltitol and sorbitol, sour agents such as citric acid, buffering agents such as phosphate, film forming agents such as shellac and zein, Lubricants such as talc and waxes, light anhydrous silicic acid, glidants such as dry aluminum hydroxide gel, diluents such as physiological saline and aqueous glucose solution, flavoring agents, coloring agents, bactericides, preservatives, A fragrance | flavor etc. can illustrate suitably. For transdermal administration compositions, hydrocarbons such as squalane, petrolatum, microcrystalline wax, esters such as jojoba oil, carnauba wax, octyldodecyl oleate, triglycerides such as olive oil, beef tallow, coconut oil, stearin Acids, fatty acids such as oleic acid and retinoic acid, lower alcohols such as ethanol and isopropanol, higher alcohols such as oleyl alcohol, stearyl alcohol and octyldodecanol, anionic surfactants such as sulfosuccinic acid ester and sodium polyoxyethylene alkyl sulfate , Amphoteric surfactants such as alkylbetaine salts, cationic surfactants such as dialkylammonium salts, sorbitan fatty acid esters, fatty acid monoglycerides, their polyoxyethylene adducts, poly Nonionic surfactants such as xylethylene alkyl ether, polyoxyethylene fatty acid ester, polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, dipropylene glycol, polyethylene glycol, glycerin, 1,3-butanediol, 1, Polyhydric alcohols such as 2-pentanediol, thickening / gelling agents, antioxidants, ultraviolet absorbers, colorants, preservatives, powders and the like can be contained. As an administration formulation, the form of external preparations, such as cosmetics, a coating agent, and a patch, is preferable.
以下にクルクミンとレスベラトロールのＤＪ−１タンパク質の産生促進効果を確認した試験例を示し、本発明の組成物の示す効果について具体的に説明する。 The test example which confirmed the production promotion effect of DJ-1 protein of curcumin and resveratrol below is shown, and the effect which the composition of this invention shows is demonstrated concretely.
＜培養ヒト皮膚角層細胞を用いたＤＪ−１タンパク質産生促進試験＞
１．試験例１
（１）試験方法
６ｗｅｌｌ ｐｌａｔｅにHaCaT細胞（ヒト表皮角化細胞株）を播種して培養し、２日後にクルクミンを０、５、１０μＭになるように添加し、３時間培養した。また同様にレスベラトロールを０、２０、４０μＭになるように添加し、３時間培養した。
培養終了後細胞を回収し、常法によって細胞を破壊して細胞内のＤＪ−１タンパク質量をウエスタンブロット法により検出した。また細胞内のアクチンタンパク質を同様にウエスタンブロット法で検出し、アクチンタンパク質量に対するＤＪ−１タンパク質量を計算し、これをＤＪ−１タンパク質産生量とした。
<DJ-1 protein production promotion test using cultured human skin horny layer cells>
1. Test example 1
(1) Test method HaCaT cells (human epidermal keratinocyte cell line) were seeded on 6-well plates and cultured, and after 2 days, curcumin was added to 0, 5, 10 μM and cultured for 3 hours. Similarly, resveratrol was added to 0, 20, and 40 μM and cultured for 3 hours.
After completion of the culture, the cells were collected, disrupted by a conventional method, and the amount of DJ-1 protein in the cells was detected by Western blotting. Similarly, intracellular actin protein was detected by Western blotting, and the amount of DJ-1 protein relative to the amount of actin protein was calculated, and this was used as the amount of DJ-1 protein produced.
（２）結果
クルクミンによる産生促進試験結果を図１、レスベラトロールによる産生促進試験結果を図２に示す。
クルクミン、レスベラトロールは、HaCaT細胞に対して作用し、ＤＪ−１タンパク質産生を促進することが確認できた。
(2) Results FIG. 1 shows the results of the production promotion test using curcumin, and FIG. 2 shows the results of the production promotion test using resveratrol.
It was confirmed that curcumin and resveratrol act on HaCaT cells and promote DJ-1 protein production.
２．試験例２（細胞への処理時間を６時間に延長）
（１）試験方法
６ｗｅｌｌ ｐｌａｔｅに正常ヒト表皮角化細胞を播種して培養し、２日後にクルクミンを０、１、３、１０、３０μＭになるように添加し、６時間培養した。また同様にレスベラトロールを０、０．００１、０．０１％になるように添加し、さらに６時間培養した。
培養終了後細胞を回収し、常法によって細胞を破壊して細胞内のＤＪ−１タンパク質量をウエスタンブロット法により検出した。サンプルを添加していない細胞のＤＪ−１タンパク質発現量を１として、それに対する比率で表記した。
2. Test Example 2 (Processing time for cells extended to 6 hours)
(1) Test method Normal human epidermal keratinocytes were seeded on a 6-well plate and cultured, and after 2 days, curcumin was added to 0, 1, 3, 10, and 30 μM and cultured for 6 hours. Similarly, resveratrol was added to 0, 0.001, and 0.01%, and further cultured for 6 hours.
After completion of the culture, the cells were collected, disrupted by a conventional method, and the amount of DJ-1 protein in the cells was detected by Western blotting. The expression level of DJ-1 protein in the cells to which no sample was added was defined as 1, and the ratio was expressed as a ratio.
（２）結果
クルクミンによる産生促進試験結果を図３、レスベラトロールによる産生促進試験結果を図４に示す。
試験例１で用いたHaCaT細胞と異なり正常ヒト表皮角化細胞の結果であるが、ともに表皮角化細胞であり、クルクミン、レスベラトロールの処理時間を延長した場合も、ヒト皮膚細胞に対して作用し、ＤＪ−１タンパク質産生を促進することが確認できた。
またレスベラトロール及びクルクミンは、紫外線などの外部刺激に対する抵抗性を向上させるため、紫外線などの外部刺激に対する抵抗性向上剤として使用できる。
(2) Results FIG. 3 shows the results of the production promotion test using curcumin, and FIG. 4 shows the results of the production promotion test using resveratrol.
Unlike the HaCaT cells used in Test Example 1, these are the results of normal human epidermal keratinocytes, but both are epidermal keratinocytes, and even when the treatment time of curcumin and resveratrol is extended, It was confirmed that it acts and promotes the production of DJ-1 protein.
Resveratrol and curcumin can be used as a resistance improver for external stimuli such as ultraviolet rays because they improve resistance to external stimuli such as ultraviolet rays.
３．試験例３（細胞の生存率に対する効果）
（１）試験方法
３５ｍｍディッシュに正常ヒト表皮角化細胞を播種し、１日後にクルクミンもしくはレスベラトロールを添加した。添加量は、クルクミンを０、１、３μＭ、レスベラトロールを０、０．０００１、０．００１％になるよう添加した。２４時間後に細胞をＰＢＳ（−）で洗浄し、ＨＡＮＫＳ液に置換してＵＶＢ１５ｍＪ／ｃｍ２を照射した。なお、細胞の生存率は、照射２４時間後にＡｌａｍａｒＢｌｕｅ ａｓｓａｙを行い、ＵＶＢ無照射、サンプル無添加細胞の蛍光強度を１として、それに対する比率で表記した。
3. Test Example 3 (Effect on cell viability)
(1) Test method Normal human epidermal keratinocytes were seeded in a 35 mm dish, and curcumin or resveratrol was added one day later. The addition amount was 0, 1, 3 μM for curcumin and 0, 0.0001, 0.001% for resveratrol. After 24 hours, the cells were washed with PBS (−), replaced with HANKS solution, and irradiated with UVB 15 mJ / cm 2 . In addition, the survival rate of the cells was expressed as a ratio with respect to the case where AlamarBlue assay was performed 24 hours after irradiation and the fluorescence intensity of the cells without UVB irradiation and without sample addition was 1.
（２）結果
クルクミンによる細胞生存率測定結果を図５、レスベラトロールによる細胞生存率測定結果を図６に示す。
クルクミン、レスベラトロールとも、紫外線照射後の細胞生存率が向上した。特にレスベラトロール０．００１質量％を添加した場合の細胞生存率は、ＵＶＢ無照射を上回った。
したがってクルクミン及びレスベラトロールは皮膚表皮細胞に対する紫外線などの外部刺激に対する抵抗性を改善することが明らかとなった。
(2) Results FIG. 5 shows the cell viability measurement results with curcumin, and FIG. 6 shows the cell viability measurement results with resveratrol.
Both curcumin and resveratrol improved cell viability after UV irradiation. In particular, the cell viability when resveratrol was added at 0.001% by mass exceeded that without UVB irradiation.
Therefore, it was revealed that curcumin and resveratrol improve the resistance to external stimuli such as ultraviolet rays on skin epidermal cells.
Claims (5)
Resistance improver against redness (redness) induced by UV exposure.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017179767 | 2017-09-20 | ||
| JP2017179767 | 2017-09-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019055932A true JP2019055932A (en) | 2019-04-11 |
| JP7061766B2 JP7061766B2 (en) | 2022-05-02 |
Family
ID=66107096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017217996A Active JP7061766B2 (en) | 2017-09-20 | 2017-11-13 | Composition for promoting DJ-1 protein production |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7061766B2 (en) |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03170416A (en) * | 1989-11-10 | 1991-07-24 | Unilever Nv | Anti-sunburn composition |
| JPH08231368A (en) * | 1995-03-01 | 1996-09-10 | Pola Chem Ind Inc | Light-aging preventing agent and skin cosmetic containing the agent |
| JP2004532790A (en) * | 2000-06-02 | 2004-10-28 | エスティー ローダー インコーポレーテッド | Using resveratrol as a sunscreen |
| JP2005112786A (en) * | 2003-10-08 | 2005-04-28 | Nikko Chemical Co Ltd | Melanin production promoter comprising curcumin derivative and utilization thereof |
| JP2009084155A (en) * | 2006-01-16 | 2009-04-23 | Kanazawa Univ | Therapeutic agent for lewy body disease and prophylactic agent for lewy body disease |
| JP2011513338A (en) * | 2008-03-03 | 2011-04-28 | スチュワート グラント，ロス | Combination therapy for cell damage |
| US20120263698A1 (en) * | 2010-10-22 | 2012-10-18 | Barber Elizabeth K | Treatment of Neurodegenerative Disease |
| WO2015156328A1 (en) * | 2014-04-09 | 2015-10-15 | 江崎グリコ株式会社 | Skin aging inhibitor and concentrate of resveratrol 3-o-α-glucoside |
| JP2016504017A (en) * | 2012-10-24 | 2016-02-12 | リージェンメドティーエックス， エルエルシー | Renal cell population and uses thereof |
| JP2017525738A (en) * | 2014-09-04 | 2017-09-07 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Topical pterostilbene composition for use in the treatment of UV-induced loss of barrier function in the skin |
-
2017
- 2017-11-13 JP JP2017217996A patent/JP7061766B2/en active Active
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03170416A (en) * | 1989-11-10 | 1991-07-24 | Unilever Nv | Anti-sunburn composition |
| JPH08231368A (en) * | 1995-03-01 | 1996-09-10 | Pola Chem Ind Inc | Light-aging preventing agent and skin cosmetic containing the agent |
| JP2004532790A (en) * | 2000-06-02 | 2004-10-28 | エスティー ローダー インコーポレーテッド | Using resveratrol as a sunscreen |
| JP2005112786A (en) * | 2003-10-08 | 2005-04-28 | Nikko Chemical Co Ltd | Melanin production promoter comprising curcumin derivative and utilization thereof |
| JP2009084155A (en) * | 2006-01-16 | 2009-04-23 | Kanazawa Univ | Therapeutic agent for lewy body disease and prophylactic agent for lewy body disease |
| JP2011513338A (en) * | 2008-03-03 | 2011-04-28 | スチュワート グラント，ロス | Combination therapy for cell damage |
| US20120263698A1 (en) * | 2010-10-22 | 2012-10-18 | Barber Elizabeth K | Treatment of Neurodegenerative Disease |
| JP2016504017A (en) * | 2012-10-24 | 2016-02-12 | リージェンメドティーエックス， エルエルシー | Renal cell population and uses thereof |
| WO2015156328A1 (en) * | 2014-04-09 | 2015-10-15 | 江崎グリコ株式会社 | Skin aging inhibitor and concentrate of resveratrol 3-o-α-glucoside |
| JP2017525738A (en) * | 2014-09-04 | 2017-09-07 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Topical pterostilbene composition for use in the treatment of UV-induced loss of barrier function in the skin |
Non-Patent Citations (2)
| Title |
|---|
| ADHAMI, V. M., ET AL., NEOPLASIA, vol. 5, no. 1, JPN6021028367, 2003, pages 74 - 82, ISSN: 0004655909 * |
| CHAN, W.-H., ET AL., JOURNAL OF CELLULAR BIOCHEMISTRY, vol. 90, no. 2, JPN6021028366, 2003, pages 327 - 338, ISSN: 0004655908 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP7061766B2 (en) | 2022-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7076534B2 (en) | Cosmetic composition containing dendrobium candidum flower extract | |
| JPWO2004016236A1 (en) | Cosmetics | |
| KR101425031B1 (en) | Cosmetic composition for anti-irritation and skin moisturization containing Citrus junos Siebold seed oil and Mangifera Indica seed oil | |
| US10137070B2 (en) | Composition including ionone or salt thereof as active ingredient and having effect of enhancing skin moisturizing, exfoliating skin, improving skin elasticity, inhibiting erythema, improving skin wrinkles, or alleviating skin photoaging | |
| Srirod et al. | Anti-inflammatory and wound healing effects of cream containing Curcuma mangga extract | |
| EP3126831A1 (en) | Method for screening trp channels | |
| JP6490342B2 (en) | Anti-skin aging agent containing Shiranui Chrysanthemum extract | |
| US11147850B2 (en) | Synergistic composition for osteoarthritis | |
| KR20160008055A (en) | Composition for improving hair or skin conditions comprising Camellia japonica leaf extract | |
| JP2012031106A (en) | Carbonylation inhibitor | |
| JP2015221790A (en) | External or internal preparation for skin containing extract of beta vulgaris rubra cultivated under irradiation with light having specific wavelength band | |
| KR101547758B1 (en) | Composition for preventing hair loss and promoting hair growth | |
| JP7061766B2 (en) | Composition for promoting DJ-1 protein production | |
| KR101343508B1 (en) | Selective extracted method for acne-prone skin antibacterial ingredient using supercuritical fluid from ginger | |
| JP2010222273A (en) | Hair-growing agent composition | |
| KR101427027B1 (en) | A Skin External Composition Containing Callus Extract Derived from Chaenomeles Sinensis | |
| JP7084687B2 (en) | Keratan sulfate production promoter | |
| EP3197458B1 (en) | Dermocosmetic or pharmaceutical use of a composition containing at least one inhibitor of certain chemoattractant cytokines | |
| JP2015221791A (en) | External or internal preparation for skin containing extract of ipomoea aquatica cultivated under irradiation with light having specific wavelength band | |
| JP6595195B2 (en) | Skin external preparation or internal preparation containing an extract of chicory cultivated by irradiation with light having a specific wavelength range | |
| KR102531790B1 (en) | Composition for skin regeneration and wound healing comprising the extract of Asparagus lucidus as an active ingredient | |
| JPH08268863A (en) | Tyrosinase biosynthesis promotor and hair cosmetic and sun-burn cosmetic | |
| JP2018177819A (en) | Composition containing specific component | |
| JP5758580B2 (en) | Proton pump inhibitor | |
| JP5590921B2 (en) | Proton pump inhibitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180214 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200626 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210720 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20210908 Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210908 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20211207 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20220113 Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220113 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220329 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220407 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7061766 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |